
Satish Rampuria
Examiner (ID: 5875, Phone: (571)272-3732 , Office: P/2193 )
| Most Active Art Unit | 2193 |
| Art Unit(s) | 2191, 2193, 2124 |
| Total Applications | 1164 |
| Issued Applications | 972 |
| Pending Applications | 64 |
| Abandoned Applications | 143 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9805752
[patent_doc_number] => 20150017696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'RECOMBINANT HOST CELLS AND PROCESSES FOR PRODUCING 1,3-BUTADIENE THROUGH A CROTONOL INTERMEDIATE'
[patent_app_type] => utility
[patent_app_number] => 14/381157
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22830
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381157
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381157 | RECOMBINANT HOST CELLS AND PROCESSES FOR PRODUCING 1,3-BUTADIENE THROUGH A CROTONOL INTERMEDIATE | Feb 25, 2013 | Abandoned |
Array
(
[id] => 9529769
[patent_doc_number] => 08753638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities'
[patent_app_type] => utility
[patent_app_number] => 13/766659
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 63
[patent_no_of_words] => 43551
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766659
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/766659 | Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities | Feb 12, 2013 | Issued |
Array
(
[id] => 8866039
[patent_doc_number] => 20130149743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'METHOD FOR ENHANCING LUMINESCENCE INTENSITY OF CLYTIN-II'
[patent_app_type] => utility
[patent_app_number] => 13/761173
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7958
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761173
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/761173 | Method for enhancing luminescence intensity of clytin-II | Feb 6, 2013 | Issued |
Array
(
[id] => 8896517
[patent_doc_number] => 08476038
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-07-02
[patent_title] => 'Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 13/761174
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7964
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/761174 | Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid | Feb 6, 2013 | Issued |
Array
(
[id] => 9793591
[patent_doc_number] => 20150005534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'CELLS AND METHODS FOR PRODUCING LUTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/377041
[patent_app_country] => US
[patent_app_date] => 2013-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26580
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377041
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377041 | Cells and methods for producing lutein | Feb 4, 2013 | Issued |
Array
(
[id] => 12405285
[patent_doc_number] => 09968690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Norbornene modified peptides and their labelling with tetrazine compounds
[patent_app_type] => utility
[patent_app_number] => 14/373292
[patent_app_country] => US
[patent_app_date] => 2013-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 45
[patent_no_of_words] => 18240
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/373292 | Norbornene modified peptides and their labelling with tetrazine compounds | Jan 20, 2013 | Issued |
Array
(
[id] => 10083508
[patent_doc_number] => 09120847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Isolation of phosphoproteins, glycoproteins and fragments thereof'
[patent_app_type] => utility
[patent_app_number] => 13/744305
[patent_app_country] => US
[patent_app_date] => 2013-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13512
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744305
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/744305 | Isolation of phosphoproteins, glycoproteins and fragments thereof | Jan 16, 2013 | Issued |
Array
(
[id] => 10083508
[patent_doc_number] => 09120847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Isolation of phosphoproteins, glycoproteins and fragments thereof'
[patent_app_type] => utility
[patent_app_number] => 13/744305
[patent_app_country] => US
[patent_app_date] => 2013-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13512
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744305
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/744305 | Isolation of phosphoproteins, glycoproteins and fragments thereof | Jan 16, 2013 | Issued |
Array
(
[id] => 9054613
[patent_doc_number] => 20130252327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'Methods Of Gene Amplification And Expression'
[patent_app_type] => utility
[patent_app_number] => 13/740694
[patent_app_country] => US
[patent_app_date] => 2013-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6229
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13740694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/740694 | Methods Of Gene Amplification And Expression | Jan 13, 2013 | Abandoned |
Array
(
[id] => 8976643
[patent_doc_number] => 20130210073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'METHODS OF INCORPORATING AMINO ACID ANALOGS INTO PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/730116
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 47631
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13730116
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/730116 | Methods of incorporating amino acid analogs into proteins | Dec 27, 2012 | Issued |
Array
(
[id] => 9838999
[patent_doc_number] => 20150031081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'METHODS AND MATERIALS FOR REDUCING DEGRADATION OF RECOMBINANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/369324
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10702
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369324
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369324 | METHODS AND MATERIALS FOR REDUCING DEGRADATION OF RECOMBINANT PROTEINS | Dec 27, 2012 | Abandoned |
Array
(
[id] => 10932067
[patent_doc_number] => 20140335087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'ASPARTYL-TRNA SYNTHETASE-FC CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/368759
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 59256
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368759
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/368759 | Aspartyl-tRNA synthetase-Fc conjugates | Dec 26, 2012 | Issued |
Array
(
[id] => 10946326
[patent_doc_number] => 20140349348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 14/365063
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12560
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365063
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/365063 | Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides | Dec 13, 2012 | Issued |
Array
(
[id] => 9785257
[patent_doc_number] => 20140302075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'ASPARTYL-TRNA SYNTHETASES'
[patent_app_type] => utility
[patent_app_number] => 14/360576
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 46480
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/360576 | Aspartyl-tRNA synthetases | Dec 5, 2012 | Issued |
Array
(
[id] => 12044762
[patent_doc_number] => 09822353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'PEGylated aspartyl-tRNA synthetase polypeptides'
[patent_app_type] => utility
[patent_app_number] => 14/360573
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 61057
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/360573 | PEGylated aspartyl-tRNA synthetase polypeptides | Dec 5, 2012 | Issued |
Array
(
[id] => 10399722
[patent_doc_number] => 20150284731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'NUCLEOTIDE SEQUENCE AND A PROCESS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/434595
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3821
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434595 | Nucleotide sequence and a process thereof | Dec 4, 2012 | Issued |
Array
(
[id] => 8733112
[patent_doc_number] => 20130078681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY HAVING ATTENUATED EXPRESSION OF GENES ENCODING A LYSINE/ARGININE/ ORNITHINE TRANSPORTER'
[patent_app_type] => utility
[patent_app_number] => 13/687353
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8885
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13687353
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/687353 | METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY HAVING ATTENUATED EXPRESSION OF GENES ENCODING A LYSINE/ARGININE/ ORNITHINE TRANSPORTER | Nov 27, 2012 | Abandoned |
Array
(
[id] => 8720661
[patent_doc_number] => 20130071878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'TWO HELIX BINDERS'
[patent_app_type] => utility
[patent_app_number] => 13/682497
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6621
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682497
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682497 | TWO HELIX BINDERS | Nov 19, 2012 | Abandoned |
Array
(
[id] => 8780694
[patent_doc_number] => 20130102669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'PERHYDROLASE VARIANT PROVIDING IMPROVED SPECIFIC ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/657601
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16953
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13657601
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/657601 | Perhydrolase variant providing improved specific activity | Oct 21, 2012 | Issued |
Array
(
[id] => 10032923
[patent_doc_number] => 09074231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Reducing non-specific enzyme binding to enhance lignocellulose conversion'
[patent_app_type] => utility
[patent_app_number] => 13/652267
[patent_app_country] => US
[patent_app_date] => 2012-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 21
[patent_no_of_words] => 17999
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/652267 | Reducing non-specific enzyme binding to enhance lignocellulose conversion | Oct 14, 2012 | Issued |